Traws Pharma Statistics
NASDAQ: TRAWHealthcareBiotechnologyUSD
0.4803+0.0013 (+0.27%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Traws Pharma by the numbers
Traws Pharma has a market capitalization of $7.4 million based on 15.37M shares outstanding. With trailing EPS of $-1.71, Traws Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.4% below its 50-day average and 61.3% below its 200-day average.
Average daily trading volume is 569.02K shares, or about $273,303 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRAW valuation vs. peer median
| Metric | TRAW | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.38M | $7.45M | -1% |
| Avg. volume | 569.02K | 173.06K | +229% |
Peer median across 8 companies: SKYE, CURX, CLGN, SNGX, LGVN, AIM, BOLT, APRE.
Valuation
- Market cap
- $7.38M
- EPS (TTM)
- $-1.71
- Shares outstanding
- 15.37M
Price and trading
- Previous close
- 0.479
- Open
- 0.4791
- Day range
- 0.4622 – 0.4806
- 52-week range
- 0.43 – 3.27
- 50-day moving average
- 0.5418
- Beta
- —
- Volume
- 99.48K
- Average volume
- 569.02K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 7.38M
- Forward Pe
- -0.26
- Eps
- -1.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.27
- Week52 Low
- 0.43
- Avg Volume
- 569.02K
- Shares Outstanding
- 15.37M
- Ma50
- 0.54
- Ma200
- 1.24
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -85.31%
- Pct From52w Low
- 11.70%